Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
Data collected includes market dynamics, technology outlook, application development, and pricing trends. All of this is fed into a research model, which then produces relevant data for market research. Global market trend analysis is given including historical data, estimates to 2023 and compound annual growth rate (CAGR) forecast to 2028.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
2023 will be a tough year for much of the global economy, as the ongoing war in Ukraine continues to strain trade, especially in Europe, and the global economy remains reeling from the fallout from the COVID-19 pandemic.
But as China moves ever closer to fully reemerging from three years of government-imposed Covid isolation and reintegrating with the world, economic expectations are high.And with the global economy now facing significant challenges, including energy shortages, slowing growth and high inflation, China's reopening could provide a much-needed and timely boost.
The report researches and analyzes the influence of the Parkinson's Disease (PD) Drugs industry in the new era of global post-COIVD-19 economy in 2023, and provides in-depth analysis and professional suggestions on the current development.
Market Segment by Product Type
- Dopamine Agonist
- Monoamine Oxidase Inhibitors
- Acetylcholinesterase Inhibitors
- Glutamate Inhibitors
Market Segment by Product Application
- Hospital
- Family
Finally, the report provides detailed profile and data information analysis of leading company.
- Boehringer Ingelheim
- GlaxoSmithKline
- Novartis
- Teva Pharmaceutical Industries
- AbbVie
- Abital Pharma
- Addex Therapeutics
- Biogen
- Eisai
- Eli Lilly
- F. Hoffmann-La Roche
- H. Lundbeck
- Impax Laboratories
- Kyowa Hakko Kirin
- Otsuka Pharmaceutical
- Pfizer
Insights and Tools:
We follow a comprehensive process to estimate market size. Key industry dynamics, regulatory scenarios, and segmental dynamics are analyzed to understand their impact on demand over the forecast period. Macroeconomic indicators such as prices, income and demographic changes, demand changes, etc. are considered in estimating market size. We also provide an in-depth profile of the key players and discuss their market shares in the global market to derive the market value. In addition, we have an internal database that is regularly updated with key insights and press releases from key stakeholders in the relevant market.
The data is generally gathered in various arrangements such as charts, graphs, infographics, trends, documents and records from various manufacturers and retailers. Our analyst gather, collect, and interpret such data to form significant databases. Our team then works with large data volumes to analyze core developments, evaluate market estimations, and identify trends.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
- 1.To study and analyze the global Parkinson's Disease (PD) Drugs consumption (value) by key regions/countries, product type and application, history data from 2018 to 2022, and forecast to 2028.
- 2.To understand the structure of Parkinson's Disease (PD) Drugs market by identifying its various subsegments.
- 3.Focuses on the key global Parkinson's Disease (PD) Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
- 4.To analyze the Parkinson's Disease (PD) Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
- 5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- 6.To project the consumption of Parkinson's Disease (PD) Drugs submarkets, with respect to key regions (along with their respective key countries).
- 7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- 8.To strategically profile the key players and comprehensively analyze their growth strategies.
Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
Table of Contents
Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
1 Market Study Overview
1.1 Study Objectives
1.2 Parkinson's Disease (PD) Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Parkinson's Disease (PD) Drugs Segment by Type
2.1.1 Dopamine Agonist
2.1.2 Monoamine Oxidase Inhibitors
2.1.3 Acetylcholinesterase Inhibitors
2.1.4 Glutamate Inhibitors
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Family
2.3 Global Parkinson's Disease (PD) Drugs Market Comparison by Regions (2018-2028)
2.3.1 Global Parkinson's Disease (PD) Drugs Market Size (2018-2028)
2.3.2 North America Parkinson's Disease (PD) Drugs Status and Prospect (2018-2028)
2.3.3 Europe Parkinson's Disease (PD) Drugs Status and Prospect (2018-2028)
2.3.4 China Parkinson's Disease (PD) Drugs Status and Prospect (2018-2028)
2.3.5 Japan Parkinson's Disease (PD) Drugs Status and Prospect (2018-2028)
2.3.6 Southeast Asia Parkinson's Disease (PD) Drugs Status and Prospect (2018-2028)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): Parkinson's Disease (PD) Drugs Industry Impact
2.5.1 Parkinson's Disease (PD) Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Parkinson's Disease (PD) Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Parkinson's Disease (PD) Drugs Sales and Market Share by Manufacturer (2018-2023)
3.2 Global Parkinson's Disease (PD) Drugs Revenue and Market Share by Manufacturer (2018-2023)
3.3 Global Parkinson's Disease (PD) Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Parkinson's Disease (PD) Drugs Manufacturer Market Share
3.5 Top 10 Parkinson's Disease (PD) Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
3.7 Key Manufacturers Parkinson's Disease (PD) Drugs Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Parkinson's Disease (PD) Drugs Industry Key Manufacturers
4.1 Boehringer Ingelheim
4.1.1 Compan Detail
4.1.2 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.1.3 Boehringer Ingelheim 159 Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.1.4 Main Business Overview
4.1.5 Boehringer Ingelheim News
4.2 GlaxoSmithKline
4.2.1 Compan Detail
4.2.2 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.2.4 Main Business Overview
4.2.5 Boehringer Ingelheim News
4.3 Novartis
4.3.1 Compan Detail
4.3.2 Novartis Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.3.4 Main Business Overview
4.3.5 Novartis News
4.4 Teva Pharmaceutical Industries
4.4.1 Compan Detail
4.4.2 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.4.4 Main Business Overview
4.4.5 Teva Pharmaceutical Industries News
4.5 AbbVie
4.5.1 Compan Detail
4.5.2 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.5.4 Main Business Overview
4.5.5 AbbVie News
4.6 Abital Pharma
4.6.1 Compan Detail
4.6.2 Abital Pharma Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.6.4 Main Business Overview
4.6.5 Abital Pharma News
4.7 Addex Therapeutics
4.7.1 Compan Detail
4.7.2 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Biogen
4.8.1 Compan Detail
4.8.2 Biogen Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.8.4 Main Business Overview
4.8.5 Biogen News
4.9 Eisai
4.9.1 Compan Detail
4.9.2 Eisai Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.9.4 Main Business Overview
4.9.5 Eisai News
4.10 Eli Lilly
4.10.1 Compan Detail
4.10.2 Eli Lilly Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.10.4 Main Business Overview
4.10.5 Eli Lilly News
4.11 F. Hoffmann-La Roche
4.11.1 Compan Detail
4.11.2 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.11.4 Main Business Overview
4.11.5 F. Hoffmann-La Roche News
4.12 H. Lundbeck
4.12.1 Compan Detail
4.12.2 H. Lundbeck Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.12.4 Main Business Overview
4.12.5 H. Lundbeck News
4.13 Impax Laboratories
4.13.1 Company Details
4.13.2 Impax Laboratories Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.13.4 Main Business Overview
4.13.5 Impax Laboratories News
4.14 Kyowa Hakko Kirin
4.14.1 Compan Detail
4.14.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.14.4 Main Business Overview
4.14.5 Kyowa Hakko Kirin News
4.15 Otsuka Pharmaceutical
4.15.1 Compan Detail
4.15.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.15.4 Main Business Overview
4.15.5 Otsuka Pharmaceutical News
4.16 Pfizer
4.16.1 Compan Detail
4.16.2 Pfizer Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.16.4 Main Business Overview
4.16.5 Pfizer News
5 Global Parkinson's Disease (PD) Drugs Market Segment by Big Type
5.1 Global Parkinson's Disease (PD) Drugs Revenue, Sales and Market Share by Big Type (2018-2023)
5.1.1 Global Parkinson's Disease (PD) Drugs Sales and Market Share by Big Type (2018-2023)
5.1.2 Global Parkinson's Disease (PD) Drugs Revenue and Market Share by Big Type (2018-2023)
5.2 Dopamine Agonist Sales Growth Rate and Price
5.2.1 Global Dopamine Agonist Sales Growth Rate (2018-2023)
5.2.2 Global Dopamine Agonist Price (2018-2023)
5.3 Monoamine Oxidase Inhibitors Sales Growth Rate and Price
5.3.1 Global Monoamine Oxidase Inhibitors Sales Growth Rate (2018-2023)
5.3.2 Global Monoamine Oxidase Inhibitors Price (2018-2023)
5.4 Acetylcholinesterase Inhibitors Sales Growth Rate and Price
5.4.1 Global Acetylcholinesterase Inhibitors Sales Growth Rate (2018-2023)
5.4.2 Global Acetylcholinesterase Inhibitors Price (2018-2023)
5.5 Glutamate Inhibitors Sales Growth Rate and Price
5.5.1 Global Glutamate Inhibitors Sales Growth Rate (2018-2023)
5.5.2 Global Glutamate Inhibitors Price (2018-2023)
6 Global Parkinson's Disease (PD) Drugs Market Segment by Big Application
6.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Big Application (2018-2023)
6.2 Hospital Sales Growth Rate (2018-2023)
6.3 Family Sales Growth Rate (2018-2023)
7 Global Parkinson's Disease (PD) Drugs Forecast
7.1 Global Parkinson's Disease (PD) Drugs Revenue, Sales and Growth Rate (2023-2028)
7.2 Parkinson's Disease (PD) Drugs Market Forecast by Regions (2023-2028)
7.2.1 North America Parkinson's Disease (PD) Drugs Market Forecast (2023-2028)
7.2.2 Europe Parkinson's Disease (PD) Drugs Market Forecast (2023-2028)
7.2.3 China Parkinson's Disease (PD) Drugs Market Forecast (2023-2028)
7.2.4 Japan Parkinson's Disease (PD) Drugs Market Forecast (2023-2028)
7.2.5 Southeast Asia Parkinson's Disease (PD) Drugs Market Forecast (2023-2028)
7.2.6 Other Regions Parkinson's Disease (PD) Drugs Market Forecast (2023-2028)
7.3 Parkinson's Disease (PD) Drugs Market Forecast by Type (2023-2028)
7.3.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2023-2028)
7.3.2 Global Parkinson's Disease (PD) Drugs Market Share Forecast by Type (2023-2028)
7.4 Parkinson's Disease (PD) Drugs Market Forecast by Application (2023-2028)
7.4.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2023-2028)
7.4.2 Global Parkinson's Disease (PD) Drugs Market Share Forecast by Application (2023-2028)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Parkinson's Disease (PD) Drugs Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Parkinson's Disease (PD) Drugs Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Parkinson's Disease (PD) Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Parkinson's Disease (PD) Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Parkinson's Disease (PD) Drugs Market Size by Big Type
Figure Global Market Share of Parkinson's Disease (PD) Drugs by Big Type in 2022
Figure Dopamine Agonist Picture (2018-2023)
Figure Monoamine Oxidase Inhibitors Picture (2018-2023)
Figure Acetylcholinesterase Inhibitors Picture (2018-2023)
Global Parkinson's Disease (PD) Drugs Market Size by Big Application
Table Global Parkinson's Disease (PD) Drugs Market Size by Application
Figure Global Parkinson's Disease (PD) Drugs Market Share by Big Application in 2022
Figure Hospital Picture
Figure Family Picture
Table Global Parkinson's Disease (PD) Drugs Comparison by Regions (M USD) ?2018-2028?
Figure Global Parkinson's Disease (PD) Drugs Market Size (Million US$) (2018-2028)
Figure North America Parkinson's Disease (PD) Drugs Revenue (Million US$) Growth Rate (2018-2028)
Figure Europe Parkinson's Disease (PD) Drugs Revenue (Million US$) Growth Rate (2018-2028)
Figure China Parkinson's Disease (PD) Drugs Revenue (Million US$) Growth Rate (2018-2028)
Figure Japan Parkinson's Disease (PD) Drugs Revenue (Million US$) Growth Rate (2018-2028)
Figure Southeast Asia Parkinson's Disease (PD) Drugs Revenue (Million US$) Growth Rate (2018-2028)
Table Business Impact Assessment - Covid-19
Table Market Trends and Parkinson's Disease (PD) Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Parkinson's Disease (PD) Drugs Sales by Manufacturer (2018-2023)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturer in 2022
Table Global Parkinson's Disease (PD) Drugs Revenue by Manufacturer (2018-2023)
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturer in 2022
Table Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Parkinson's Disease (PD) Drugs Manufacturer (Revenue) Market Share in 2022
Figure Top 10 Parkinson's Disease (PD) Drugs Manufacturer (Revenue) Market Share in 2022
Table Date of Key Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
Table Key Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table Mergers & Acquisitions Planning
Table Boehringer Ingelheim Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Boehringer Ingelheim
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2018-2023
Table Company One Main Business
Table Company One Recent Development
Table GlaxoSmithKline Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of GlaxoSmithKline
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table GlaxoSmithKline Recent Development
Table Novartis Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Novartis
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Novartis Main Business
Table Novartis Recent Development
Table Teva Pharmaceutical Industries Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Teva Pharmaceutical Industries
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Teva Pharmaceutical Industries Main Business
Table Teva Pharmaceutical Industries Recent Development
Table Teva Pharmaceutical Industries Main Business
Table Teva Pharmaceutical Industries Recent Development
Table AbbVie Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of AbbVie
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table AbbVie Main Business
Table AbbVie Recent Development
Table Abital Pharma Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Abital Pharma
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Abital Pharma Main Business
Table Abital Pharma Recent Development
Table Addex Therapeutics Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Addex Therapeutics
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Addex Therapeutics Main Business
Table Addex Therapeutics Recent Development
Table Biogen Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Biogen
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Biogen Main Business
Table Biogen Recent Development
Table Eisai Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Eisai
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Eisai Main Business
Table Eisai Recent Development
Table Eli Lilly Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Eli Lilly
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table F. Hoffmann-La Roche Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of F. Hoffmann-La Roche
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table F. Hoffmann-La Roche Main Business
Table F. Hoffmann-La Roche Recent Development
Table H. Lundbeck Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of H. Lundbeck
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table H. Lundbeck Main Business
Table H. Lundbeck Recent Development
Table Impax Laboratories Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Impax Laboratories
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Impax Laboratories Main Business
Table Impax Laboratories Recent Development
Table Kyowa Hakko Kirin Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Kyowa Hakko Kirin
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Kyowa Hakko Kirin Main Business
Table Kyowa Hakko Kirin Recent Development
Table Pfizer Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Pfizer
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Pfizer Main Business
Table Pfizer Recent Development
Figure Global Parkinson's Disease (PD) Drugs Sales and Growth Rate (2018-2023)
Figure Global Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2018-2023)
Table Global Parkinson's Disease (PD) Drugs Sales by Regions (2018-2023)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions in 2022
Table Global Parkinson's Disease (PD) Drugs Revenue by Regions (2018-2023)
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions in 2022
Figure North America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2018-2023)
Figure Europe Parkinson's Disease (PD) Drugs Sales and Growth Rate (2018-2023)
Figure China Parkinson's Disease (PD) Drugs Sales and Growth Rate (2018-2023)
Figure Japan Parkinson's Disease (PD) Drugs Sales and Growth Rate (2018-2023)
Figure Southeast Asia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2018-2023)
Figure Other Regions Parkinson's Disease (PD) Drugs Sales and Growth Rate (2018-2023)
Table Global Parkinson's Disease (PD) Drugs Sales by Big Type (2018-2023)
Table Global Parkinson's Disease (PD) Drugs Sales Market Share by Big Type (2018-2023)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Big Type in 2020
Table Global Parkinson's Disease (PD) Drugs Revenue by Big Type (2018-2023)
Table Global Parkinson's Disease (PD) Drugs Revenue Market Share by Big Type (2018-2023)
Table Global Parkinson's Disease (PD) Drugs Revenue Market Share by Big Type in 2020
Figure Global Dopamine Agonist Sales Growth Rate (2018-2023)
Figure Global Dopamine Agonist Price (2018-2023)
Figure Global Monoamine Oxidase Inhibitors Sales Growth Rate (2018-2023)
Figure Global Monoamine Oxidase Inhibitors Price (2018-2023)
Figure Global Acetylcholinesterase Inhibitors Sales Growth Rate (2018-2023)
Figure Global Acetylcholinesterase Inhibitors Price (2018-2023)
Figure Global Glutamate Inhibitors Sales Growth Rate (2018-2023)
Table Global Parkinson's Disease (PD) Drugs Sales by Big Application (2018-2023)
Table Global Parkinson's Disease (PD) Drugs Sales Market Share by Big Application (2018-2023)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Big Application in 2020
Figure Global Hospital Sales Growth Rate (2018-2023)
Figure Global Family Sales Growth Rate (2018-2023)
Figure Global Parkinson's Disease (PD) Drugs Sales and Growth Rate (2023-2028)
Figure Global Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2023-2028)
Table Global Parkinson's Disease (PD) Drugs Sales Forecast by Regions (2023-2028)
Table Global Parkinson's Disease (PD) Drugs Market Share Forecast by Regions (2023-2028)
Figure North America Sales Parkinson's Disease (PD) Drugs Market Forecast (2023-2028)
Figure Europe Sales Parkinson's Disease (PD) Drugs Market Forecast (2023-2028)
Figure China Sales Parkinson's Disease (PD) Drugs Market Forecast (2023-2028)
Figure Japan Sales Parkinson's Disease (PD) Drugs Market Forecast (2023-2028)
Figure Southeast Asia Sales Parkinson's Disease (PD) Drugs Market Forecast (2023-2028)
Figure Other Regions Sales Parkinson's Disease (PD) Drugs Market Forecast (2023-2028)
Table Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2023-2028)
Table Global Parkinson's Disease (PD) Drugs Market Share Forecast by Type (2023-2028)
Table Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2023-2028)
Table Global Parkinson's Disease (PD) Drugs Market Share Forecast by Application (2023-2028)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinson's Disease (PD) Drugs
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Parkinson's Disease (PD) Drugs Sales (K Units) Growth Rate Forecast (2022-2026)
Figure North America Parkinson's Disease (PD) Drugs Revenue (Million US$) Growth Rate Forecast (2022-2026)
Figure Europe Parkinson's Disease (PD) Drugs Sales (K Units) Growth Rate Forecast (2022-2026)
Figure Europe Parkinson's Disease (PD) Drugs Revenue (Million US$) Growth Rate Forecast (2022-2026)
Figure Japan Parkinson's Disease (PD) Drugs Production (K Units) Growth Rate Forecast (2022-2026)
Figure Japan Parkinson's Disease (PD) Drugs Revenue (Million US$) Growth Rate Forecast (2022-2026)
Figure China Parkinson's Disease (PD) Drugs Production (K Units) Growth Rate Forecast (2022-2026)
Figure China Parkinson's Disease (PD) Drugs Revenue (Million US$) Growth Rate Forecast (2022-2026)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Global Parkinson's Disease Therapeutics Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 99
Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......
Global Amantadine Hydrochloride Market Insights, Forecast to 2029
Published: 29-Aug-2023 Price: US 4900 Onwards Pages: 109
Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder.
The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......
Global Rasagiline Tablet Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 107
Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.
The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......
Global Parkinsons Disease Drug Market Insights, Forecast to 2029
Published: 02-Aug-2023 Price: US 4900 Onwards Pages: 113
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
Global P......
Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028
Published: 20-Mar-2023 Price: US 2680 Onwards Pages: 137
Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028
Published: 20-Mar-2023 Price: US 3280 Onwards Pages: 109
Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
Global Amantadine Hydrochloride Market Research Report 2023
Published: 09-Mar-2023 Price: US 2900 Onwards Pages: 98
Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder.
Highlights
The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Amantadine hydrochloride is clinically effective......
Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028
Published: 21-Feb-2023 Price: US 3280 Onwards Pages: 133
Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
Published: 21-Feb-2023 Price: US 2680 Onwards Pages: 159
Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
